Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Carroll

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Gastroenterology|December 16, 2025
Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 DiabetesJonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 30, 2018
Predictors of Varenicline Adherence Among Cancer Patients Treated for Tobacco Dependence and its Association With Smoking CessationGrace Crawford, Jessica Weisbrot, Joseph Bastian, et al.
JAMA Internal Medicine|March 17, 2025
Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver DiseaseJonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|November 15, 2023
Organ Donation in Canadian PICUs: A Cross-Sectional Survey, 2021-2022Laurie A Lee, Dori-Ann Martin, Meagan Mahoney, et al.
Hepatology Communications|April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetesJonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.
Clinical and Molecular Hepatology|November 11, 2025
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate FibrosisJonggi Choi, Daniel Fulop, Vy H Nguyen, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulationJonggi Choi, Ana Verma, Vy H Nguyen, et al.
The American Journal of Gastroenterology|May 12, 2026
GLP-1 receptor agonist use and liver-related outcomes in MASLD and type 2 diabetes in the All of Us Research ProgramErik Almazan, Jonggi Choi, Tushar Kamath, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2025
GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score MatchingJonggi Choi, Tushar Kamath, Vy H Nguyen, et al.
Hepatology (Baltimore, Md.)|February 2, 2026
Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation studyJonggi Choi, Junqing Xu, Vy H Nguyen, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Gastroenterology|December 16, 2025
Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 DiabetesJonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 30, 2018
Predictors of Varenicline Adherence Among Cancer Patients Treated for Tobacco Dependence and its Association With Smoking CessationGrace Crawford, Jessica Weisbrot, Joseph Bastian, et al.
JAMA Internal Medicine|March 17, 2025
Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver DiseaseJonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|November 15, 2023
Organ Donation in Canadian PICUs: A Cross-Sectional Survey, 2021-2022Laurie A Lee, Dori-Ann Martin, Meagan Mahoney, et al.
Hepatology Communications|April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetesJonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.
Clinical and Molecular Hepatology|November 11, 2025
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate FibrosisJonggi Choi, Daniel Fulop, Vy H Nguyen, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulationJonggi Choi, Ana Verma, Vy H Nguyen, et al.
The American Journal of Gastroenterology|May 12, 2026
GLP-1 receptor agonist use and liver-related outcomes in MASLD and type 2 diabetes in the All of Us Research ProgramErik Almazan, Jonggi Choi, Tushar Kamath, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2025
GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score MatchingJonggi Choi, Tushar Kamath, Vy H Nguyen, et al.
Hepatology (Baltimore, Md.)|February 2, 2026
Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation studyJonggi Choi, Junqing Xu, Vy H Nguyen, et al.
Pageof 3